Endoscopy 2007; 39(8): 692-700
DOI: 10.1055/s-2007-966578
Original article

© Georg Thieme Verlag KG Stuttgart · New York

A study of the safety of current gastrointestinal endoscopy (EGD)

D.  J.  McLernon1 , P.  T.  Donnan1 , A.  Crozier2 , J.  Dillon3 , C.  Mowat3
  • 1Tayside Centre for General Practice, Health Informatics Centre, Community Health Sciences, University of Dundee, Dundee, United Kingdom
  • 2Department of Clinical Measurement, University of Dundee, Dundee, United Kingdom
  • 3Department of Digestive Diseases and Clinical Nutrition, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom
Further Information

Publication History

eingereicht 1 September 2006

akzeptiert 2 April 2007

Publication Date:
30 July 2007 (online)

Background and study aims: Previous attempts at assessing the safety of upper gastrointestinal endoscopy have been hampered by incomplete data collection. We aimed to assess the 30-day mortality associated with esophagogastroduodenoscopy (EGD) and assess the important risk factors.

Patients and methods: A retrospective cohort study was conducted of patients who underwent endoscopy at Ninewells Hospital in Dundee between 1 June 2000 and 31 May 2003. A total of 11 501 EGDs were performed in 8926 patients. These patients were record-linked to the death registry and the database of hospital admissions in order to calculate the all-cause 30-day mortality. An expert panel judged whether EGD had caused or contributed to the deaths. Logistic regression analysis was performed on outcomes of all-cause and EGD-contributed mortality.

Results: The median age of the patients was 62 years (interquartile range 48 - 74 years), 54 % were women, and 94 % of procedures were diagnostic. A total of 395 patients died within 30 days (all-cause 30-day mortality rate 4.4 %). One patient death was caused directly by the EGD (procedure-caused mortality rate 1 in 9000). EGD was judged to have contributed to patient deaths at a rate of 1 in 182, based on majority agreement of experts: some factors associated with these deaths were percutaneous endoscopic gastrostomy insertion (odds ratio [OR] 18.39, 95 % confidence interval [CI] 5.71 - 59.22), melena or hematemesis indications (OR 9.01, 95 % CI 3.53 - 22.99), and esophageal varices (OR 6.28, 95 % CI 1.54 - 25.60).

Conclusions: A causal death rate of 1 in 9000 suggests that EGD is very safe. However, certain patient groups have an increased mortality, and the risks and benefits of EGD should be carefully evaluated in each patient.

References

  • 1 Quine M A, Bell G D, McCloy R F. et al . A prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing and sedation methods.  Gut. 1995;  36 462-467
  • 2 Barlow D, Bell G D, Chalmers A H. et al. and UK Academy of Medical Royal Colleges and their Faculties .Implementing and ensuring safe sedation practice for healthcare procedures in adults: report of an intercollegiate working party chaired by the Royal College of Anaesthetists, 2001. Available from: http://www.rcoa.ac.uk/docs/safesedationpractice.pdf
  • 3 Cullinane M, Gray A JG, Hargraves C MK. et al .Scoping our practice: the 2004 report of the National Confidential Enquiry into Patient Outcome and Death (NCEPOD). Available from:http://www.ncepod.org.uk/2004report/index.htm
  • 4 Callahan C M, Haag K M, Weinberger M. et al . Outcomes of percutaneous endoscopic gastrostomy among older adults in a community setting.  J Am Geriatr Soc. 2000;  48 1048-1054
  • 5 Forbes R B, Colville S, Swingler R J. and the Scottish Motor Neurone Disease Research Group . Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease - a record linkage study from the Scottish Motor Neurone Disease Register.  J Neurol. 2004;  251 813-817
  • 6 Dennis M S, Lewis S C, Warlow C. et al . Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial.  Lancet. 2005;  365 764-772
  • 7 Clarke I, Dunnet C, Camp J. et al .Management of patients with stroke: identification and management of dysphagia. A national clinical guideline. Scottish Intercollegiate Guidelines Network (SIGN). Scotland: SIGN 2004
  • 8 Evans J MM, McDevitt D G, MacDonald T M. The Tayside Medicines Monitoring Unit (MEMO): a record-linkage system for pharmacovigilance.  Pharm Med. 1995;  9 177-184
  • 9 Light V L, Slezak F A, Porter J A. et al . Predictive factors for early mortality after percutaneous endoscopic gastrostomy.  Gastrointest Endosc. 1995;  42 330-335
  • 10 Bourdel-Marchasson I, Dumas F, Pinganaud G. et al . Audit of percutaneous endoscopic gastrostomy in long-term enteral feeding in a nursing home.  Int J Qual Health Care. 1997;  9 297-302
  • 11 Onishi J, Kuzuya M, Sakaguchi H. Survival rate alter percutaneous endoscopic gastrostomy in a long-term care hospital [letter].  Clin Nutr. 2004;  23 1248-1249

D. McLernon, MPhil

Tayside Centre for General Practice

Community Health Sciences

Mackenzie Building

University of Dundee

Kirsty Semple Way

Dundee DD2 4BF

United Kingdom

Fax: +44-1382-420010

Email: d.mclernon@chs.dundee.ac.uk

    >